Dosing Regimen Recommendation via Ethnic Sensitivity Analysis
For drugs developed simultaneously in China and the US, we utilize existing domestic and overseas healthy volunteer data, conduct ethnic sensitivity analysis combined with domestic Phase I clinical data, and propose an appropriate dosing regimen for Phase II clinical trials.
B²O Pharma is an innovative pharmaceutical R&D enterprise focusing on AI-driven clinical pharmacology and quantitative pharmacology, dedicated to advancing model-informed drug development.